Barclays’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.75M | Buy |
321,166
+135,800
| +73% | +$2.85M | ﹤0.01% | 1394 |
|
|
2025
Q1 | $3.04M | Sell |
185,366
-13,390
| -7% | -$219K | ﹤0.01% | 1753 |
|
|
2024
Q4 | $5.11M | Buy |
198,756
+17,586
| +10% | +$452K | ﹤0.01% | 1591 |
|
|
2024
Q3 | $5.74M | Buy |
181,170
+118,438
| +189% | +$3.75M | ﹤0.01% | 1435 |
|
|
2024
Q2 | $2.2M | Sell |
62,732
-7,234
| -10% | -$254K | ﹤0.01% | 1633 |
|
|
2024
Q1 | $3.07M | Sell |
69,966
-106,474
| -60% | -$4.67M | ﹤0.01% | 1653 |
|
|
2023
Q4 | $6.28M | Buy |
176,440
+90,114
| +104% | +$3.21M | ﹤0.01% | 1340 |
|
|
2023
Q3 | $2.33M | Buy |
86,326
+13,049
| +18% | +$352K | ﹤0.01% | 1573 |
|
|
2023
Q2 | $1.72M | Buy |
73,277
+11,020
| +18% | +$259K | ﹤0.01% | 1827 |
|
|
2023
Q1 | $855K | Sell |
62,257
-32,086
| -34% | -$441K | ﹤0.01% | 2244 |
|
|
2022
Q4 | $1.72M | Buy |
94,343
+23,735
| +34% | +$431K | ﹤0.01% | 1731 |
|
|
2022
Q3 | $1.05M | Buy |
70,608
+68,244
| +2,887% | +$1.02M | ﹤0.01% | 2085 |
|
|
2022
Q2 | $33K | Sell |
2,364
-3,078
| -57% | -$43K | ﹤0.01% | 3898 |
|
|
2022
Q1 | $61K | Sell |
5,442
-34,318
| -86% | -$385K | ﹤0.01% | 3919 |
|
|
2021
Q4 | $940K | Buy |
39,760
+26,173
| +193% | +$619K | ﹤0.01% | 2240 |
|
|
2021
Q3 | $347K | Buy |
13,587
+1,540
| +13% | +$39.3K | ﹤0.01% | 2755 |
|
|
2021
Q2 | $252K | Sell |
12,047
-2,809
| -19% | -$58.8K | ﹤0.01% | 2794 |
|
|
2021
Q1 | $348K | Buy |
14,856
+9,616
| +184% | +$225K | ﹤0.01% | 2863 |
|
|
2020
Q4 | $73K | Sell |
5,240
-2,036
| -28% | -$28.4K | ﹤0.01% | 3066 |
|
|
2020
Q3 | $91K | Buy |
7,276
+648
| +10% | +$8.1K | ﹤0.01% | 3072 |
|
|
2020
Q2 | $94K | Buy |
+6,628
| New | +$94K | ﹤0.01% | 3144 |
|